Biocom CRO Workshop: Dr. Aruna Somasiri on Utilization of IHC in Novel Biomarker Identification
We are pleased to announce that Dr. Aruna Somasiri, President, Wax-it Histology Services, has been invited to speak at the Biocom CRO workshop to share his expertise on using immunohistochemistry (IHC) to discover and analyze novel biomarkers. The Biocom CRO workshop will be held in San Diego on April 10, 2014 from 8AM to 10AM PST.
The Importance of IHC in Biomarker Analysis & Discovery
Biomarkers play an important role in preclinical studies, identifying potential drug targets, and preventing toxicities. IHC is critical in determining biomarker detection, localization, and semi-quantitative expression levels. Through multi-panel IHC testing, one can determine the expression of multiple biomarkers in a biopsied sample with a high level of sensitivity and specificity. Dr. Somasiri will expand on the topic of IHC and biomarker analysis and discovery during the Biocom CRO workshop in April.
Biocom CRO Workshop: Technologies for Discovering & Analyzing Novel Biomarkers
The Biocom CRO workshop will focus on strategies for discovering and analyzing novel biomarkers using three distinct technologies: immunohistochemical, bioanalytical, and genomic approaches.
The full speaker panel for this workshop is as follows:
- Aruna Somasiri, PhD. MBA: President, Wax-it Histology Services, Inc.
- Dan Kassel, PhD: Founder and CEO, SciAnalytical
- Jeffrey Shaman, Ph.D.: Business Development Lead, Translational Genomics, GeneWiz
Request a Complimentary Consultation
To discuss your study requiring immunohistochemistry, contact Wax-it Histology Services
via email at firstname.lastname@example.org
or by phone at 604.822.1595 for a complimentary scientific consultation.
About Wax-it Histology Services, Inc.
Incorporated in 2003, Wax-it Histology Services, Inc. brings a wealth of knowledge to our internationally recognized pharmaceutical, biotechnology, and medical device partners. Wax-it Histology Services, Inc. is a GLP-recognized CRO that offers general histology services (paraffin and frozen), immunohistochemistry services (general IHC, cross-reactivity studies, antibody and biomarker testing/validation), GLP and non-GLP histopathology for preclinical toxicology studies, and resin/plastic sectioning for implantable medical devices and bone.